Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 30:10:364.
doi: 10.3389/fcimb.2020.00364. eCollection 2020.

Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis

Milos Jesenak  1   2   3 , Miroslava Brndiarova  1 , Ingrid Urbancikova  4   5 , Zuzana Rennerova  6   7 , Jarmila Vojtkova  1 , Anna Bobcakova  2 , Robert Ostro  4 , Peter Banovcin  1
Affiliations
Review

Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis

Milos Jesenak et al. Front Cell Infect Microbiol. .

Abstract

Severe acute respiratory syndrome caused by a novel 2019 coronavirus (SARS-CoV2) represents one of the most studied infectious diseases of today. The number of scientific reports and publications increases exponentially day by day. While the majority of infected subjects are asymptomatic or show mild symptoms, there is an important proportion of patients who requires hospitalization and, sometimes, intensive care. Immune response to novel coronavirus is complex, involves both innate and adaptive immunity, and is biphasic. Significant differences were observed when comparing severe and non-severe patients. Analysis of the reported results from clinical trials clearly show an involvement of specific cellular immunity (predominantly leucopenia, decreased counts of CD3+, CD4+, and CD8+ T lymphocytes, changes of T cell compartment) and the so-called cytokine storm, which is associated with worsening of symptoms and the promotion of lung damage. An interesting finding regarding eosinopenia that can have both diagnostic and prognostic value is reported by some authors. Examination of selected immune parameters could help to identify severe patients with the risk of unfavorable course of the disease, predict the prognosis and recognize improvement in the clinical status. Moreover, detailed analysis of the immune changes could help to select novel prospective therapeutic strategies.

Keywords: COVID-19; SARS-CoV2; coronavirus 2019; cytokine storm; eosinopenia; immunoparalysis; lymphopenia.

PubMed Disclaimer

References

    1. Bedirli A., Kerem M., Pasaoglu H., Akyurek N., Tezcaner T., Elbeg S., et al. (2007). Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis. Shock 27, 397–401. 10.1097/01.shk.0000245030.24235.f1 - DOI - PubMed
    1. Beran J., Salapova E., Spajdel M. (2016). Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a phase 4, randomized, placebo-controlled, double-blind study. BMC Infect. Dis. 16:648. 10.1186/s12879-016-1965-5 - DOI - PMC - PubMed
    1. Bergendiova K., Tibenska E., Majtan J. (2011). Pleuran (β-glucan from pleurotus ostreatus) supplementation, cellular immune response and respiratory tract infections in athletes. Eur. J. Appl. Physiol. 111, 2033–2040. 10.1007/s00421-011-1837-z - DOI - PubMed
    1. Bermejo-Martin J. F., Almansa R., Menendez R., Mendez R., Kelvin D. J., Torres A. (2020). Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection. J. Infect. 80, e23–e24. 10.1016/j.jinf.2020.02.029 - DOI - PMC - PubMed
    1. Bobovak M., Kuniakova R., Gabriz J., Majtan J. (2010). Effect of pleuran (β-glucan from Pleurotus ostreatus) supplementation on cellular immune response after intensive exercise in elite athletes. Appl. Physiol. Nutr. Metab. 35, 755–762. 10.1139/H10-070 - DOI - PubMed

Publication types